Jump to the top of the page

William Blair Thinking

How Insurers are Embracing Technology and Change in an Evolving Risk Environment

In this episode of William Blair Thinking Presents, technology analyst Dylan Becker joins Adam Klauber, group head of the financial services and technology research sector, to discuss highlights from the seventh annual William Blair Insurance, Banking, and Wealth Technology Conference. They delve into key trends in the insurance technology space, including labor constraints, legacy modernization, and the integration of AI infrastructure.

Listen to the podcast

Liquidity Options Without Giving Up Control of Your Business

For leaders of founder-owned businesses, raising significant capital without relinquishing control can seem challenging. But investors focused on non-control transactions are becoming more common—creating opportunities to support growth, strategic acquisitions, and personal liquidity.

Read more

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

William Blair Expands Private Capital Advisory Group in Europe

William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, announced today the expansion of the firm’s Private Capital Advisory team in Europe with the addition of Connor O’Keeffe as managing director. Based in London, O’Keeffe will focus on fund placement and advisory services for general partners (GPs) throughout Europe.

Read more

Tenax Therapeutics, Inc.: Initiation of Research Coverage

William Blair initiated research coverage of Tenax Therapeutics, Inc. (TENX $3.45). Tenax is focused on pulmonary and cardiovascular diseases, including lead program levosimendan for the treatment of pulmonary hypertension in patients with heart failure with preserved ejection fraction (PH-HFpEF).

Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures